Wingspan M003WS0300150Recalls & reported problems
Stryker Corporation · Stent System · Class f · Implant
All models of Wingspan (12)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 04546540722805), received between Aug 4, 2016 and Mar 30, 2020 — classified as 2 injuries, 5 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Break2
- Fracture1
- Premature Activation1
- Premature Separation1
Patient problems
- No Consequences Or Impact To Patient5
- Hemorrhage, Cerebral1
- Neurological Deficit/Dysfunction1
- Stroke/CVA1
- Thrombosis1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 30, 2020Fracture; Fracture
IT WAS REPORTED THAT DURING THE PROCEDURE PUSHER WIRE OF THE STENT DELIVERY SYSTEM (SUBJECT DEVICE) MAY HAVE BROKEN OR BENT INSIDE THE MICROCATHETER. THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9899220 ↗MalfunctionAug 14, 2019Break; Break
IT WAS REPORTED THE STENT INNER BODY BROKE INSIDE THE PATIENT. THERE WAS NO CLINICAL CONSEQUENCE REPORTED DUE TO THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8893844 ↗MalfunctionAug 13, 2019Premature Separation; Premature Separation
IT WAS REPORTED THE STENT (SUBJECT DEVICE) PREMATURELY DEPLOYEDINSIDE THE PATIENT. THERE WAS NO WAS NO CLINICAL CONSEQUENCE REPORTED DUE TO THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8890714 ↗MalfunctionOct 11, 2017Break; Break
IT WAS REPORTED THAT THE INNER BODY TIP ON THE STENT STABILIZER SYSTEM SEPARATED UPON WITHDRAWAL OF SYSTEM AFTER STENT DEPLOYMENT. THERE WERE NO REPORTED CLINICAL CONSEQUENCES TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6942624 ↗InjuryApr 25, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT UNDERWENT A NEURO STENTING (SUBJECT DEVICE) SURGICAL PROCEDURE TO PLACE A STENT IN THE LICA (LEFT INTERNAL CAROTID ARTERY) AND LMCA (LEFT MIDDLE CEREBRAL ARTERY). IT WAS REPORTED THAT POST PROCEDURE, THE PATIENT SUFFERED FROM A LARGE LEFT MCA STROKE. FURTHER HOSPITALIZATION OF THE PATIENT WAS COMPLICATED BY ASPIRATION RESULTING IN MDR (MULTIDRUG-RESISTANT) PNEUMONIA WITH ACUTE HYPOXIC FAILURE AND ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) REQUIRING INTUBATION. THE PATIENT ALSO DEVELOPED A LOWER GI (GASTROINTESTINAL) BLEED. IN ADDITION, THE LICA/MCA STENTED AREAS WENT ON TO OCCLUDE AND A PONTINE INTRACEREBRAL HEMORRHAGE ALSO OCCURRED. IT WAS REPORTED THAT THE PATIENT PASSED AWAY DUE TO CARDIOPULMONARY ARREST APPROXIMATELY 17 DAYS POST THE INDEX PROCEDURE. THE PHYSICIAN HAS STATED THAT THE STENT(S) DID NOT MALFUNCTION. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Hemorrhage, Cerebral; Stroke/CVA; Thrombosis
MAUDE report 6519945 ↗InjuryOct 25, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT FOLLOWING ANGIOPLASTY WITH THE BALLOON CATHETER, A STENT (SUBJECT DEVICE) WAS PLACED ACROSS THE 76% STENOSED RIGHT MIDDLE CEREBRAL ARTERY (MCA) M1 LESION. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH THE IMPROVEMENT IN THE LUMINAL DIAMETER. POST PROCEDURE, THE FOLLOWING DAY THE PATIENT COMPLAINED OF DIFFICULTY LIFTING LEFT LOWER EXTREMITY FROM BED. THE PHYSICIAN ASSESSED THE PATIENT¿S ABILITY TO LIFT THE LEFT LEG AND THE STRENGTH OF THE LEG AS 4+. THE FLUID BOLUS (UNSPECIFIED) WAS ADMINISTERED TO TREAT THE PATIENT. THIS EVENT WAS RESOLVED WITHOUT ANY RESIDUAL EFFECT. THE PATIENT WAS DISCHARGED HOME WITH THE MODIFIED RANKIN SCALE (MRS) SCORE OF 0. AS PER THE PHYSICIAN¿S OPINION THE PATIENT¿S OUTCOME IS RELATED TO THE PROCEDURE HOWEVER IT IS UNKNOWN IF IT IS RELATED TO THE DEVICE.
Patient problems: Neurological Deficit/Dysfunction
MAUDE report 6054377 ↗MalfunctionAug 4, 2016Premature Activation; Premature Activation
ANALYSIS OF THE RETURNED DEVICE REVEALED THAT THE STENT HAD PREMATURELY DEPLOYED DURING USE. NO CONSEQUENCES TO THE PATIENT WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 5848394 ↗
Other intracranial neurovascular stent devices
- CERENOVUS ENTERPRISE ENF402312Medos International Sàrl · intracranial neurovascular stent1 death90 reports
- PulseRider Aneurysm Neck Reconstruction Device 201-DMedos International Sàrl · Intracranial Neurovascular Stent2 deaths74 reports
- CERENOVUS ENTERPRISE ENF402300Medos International Sàrl · intracranial neurovascular stent2 deaths66 reports
- CERENOVUS ENTERPRISE ENF403012Medos International Sàrl · intracranial neurovascular stent1 death42 reports
- CERENOVUS ENTERPRISE ENF452212Medos International Sàrl · intracranial neurovascular stent41 reports
- CERENOVUS ENTERPRISE ENF401600Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF401612Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF452812Medos International Sàrl · intracranial neurovascular stent31 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page